Evommune, Inc.
EVMN
$18.41
-$1.82-9.00%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.57M | -14.56M | -18.32M | -18.32M | -27.38M |
| Total Depreciation and Amortization | 375.00K | 377.00K | 345.50K | 345.50K | 325.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.75M | 244.00K | 62.50K | 62.50K | -62.00K |
| Change in Net Operating Assets | -4.27M | -9.96M | -4.46M | -4.46M | 18.49M |
| Cash from Operations | -26.21M | -23.90M | -22.37M | -22.37M | -8.63M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.00M | 13.50M | -11.83M | -11.83M | 10.05M |
| Cash from Investing | 18.00M | 13.50M | -11.83M | -11.83M | 10.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -155.00K | -154.00K | -126.50K | -126.50K | -108.00K |
| Issuance of Common Stock | 4.00K | 2.00K | 5.50K | 5.50K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 65.23M | -- | 24.91M | 24.91M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -736.00K | -- | -- | -- | -- |
| Cash from Financing | 64.34M | -152.00K | 24.79M | 24.79M | -108.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.13M | -10.55M | -9.41M | -9.41M | 1.29M |